139 related articles for article (PubMed ID: 2303288)
1. DNA-ploidy as prognostic factor in prostatic carcinoma.
Haugen OA; Mjølnerød O
Int J Cancer; 1990 Feb; 45(2):224-8. PubMed ID: 2303288
[TBL] [Abstract][Full Text] [Related]
2. Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S; Nordling S; Lipponen P; Talja M; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):309-14. PubMed ID: 8054280
[TBL] [Abstract][Full Text] [Related]
3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
4. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate.
Ritchie AW; Dorey F; Layfield LJ; Hannah J; Lovrekovich H; deKernion JB
Br J Urol; 1988 Sep; 62(3):245-60. PubMed ID: 3191338
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA analysis of stage D2 prostatic carcinoma.
Yokogi H; Mizutani M; Ishibe T
Urol Int; 1991; 47(2):57-9. PubMed ID: 1792707
[TBL] [Abstract][Full Text] [Related]
6. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
7. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
Ishikawa A
Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of nuclear DNA content in prostatic carcinoma.
Forsslund G; Esposti PL; Nilsson B; Zetterberg A
Cancer; 1992 Mar; 69(6):1432-9. PubMed ID: 1540880
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
10. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
11. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma.
Miller J; Horsfall DJ; Marshall VR; Rao DM; Leong SY
J Urol; 1991 Jun; 145(6):1192-6. PubMed ID: 2033691
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy, S phase fraction and G2 fraction as prognostic determinants in prostatic adenocarcinoma.
Eskelinen M; Lipponen P; Majapuro R; Syrjänen K; Nordling S
Eur Urol; 1991; 20(1):62-6. PubMed ID: 1743234
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
Borre M; Høyer M; Nerstrøm B; Overgaard J
Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
18. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
